BG107519A - МЕТОД ЗА ПОЛУЧАВАНЕ НА ИМИДАЗО (1,2-c) (2,3) БЕНЗОДИАЗЕПИНИ И МЕЖДИННИ ПРОДУКТИ ПРИ ТЯХНОТО ПОЛУЧАВАНЕ - Google Patents

МЕТОД ЗА ПОЛУЧАВАНЕ НА ИМИДАЗО (1,2-c) (2,3) БЕНЗОДИАЗЕПИНИ И МЕЖДИННИ ПРОДУКТИ ПРИ ТЯХНОТО ПОЛУЧАВАНЕ Download PDF

Info

Publication number: BG107519A
Authority: BG; Bulgaria
Prior art keywords: halogen; alkoxy; general formula; hydroxy; alkyl
Prior art date: 2000-08-10

Application number

BG107519A

Other languages

Bulgarian (bg)

English (en)

Inventor

Eric Winter

Matthias Schneider

Ulf Tilstam

Original Assignee

Schering Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-10

Filing date

2003-02-04

Publication date

2003-06-30

2003-02-04 Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft

2003-06-30 Publication of BG107519A publication Critical patent/BG107519A/bg

Links

238000000034 method Methods 0.000 title claims abstract description 16
JENALEDAZIFLGS-UHFFFAOYSA-N 3h-imidazo[1,2-c][2,3]benzodiazepine Chemical class C1=NN2CC=NC2=CC2=CC=CC=C21 JENALEDAZIFLGS-UHFFFAOYSA-N 0.000 title claims description 9
239000000543 intermediate Substances 0.000 title abstract description 5
238000004519 manufacturing process Methods 0.000 title abstract description 4
150000001875 compounds Chemical class 0.000 claims abstract description 29
239000000203 mixture Substances 0.000 claims abstract description 11
238000002360 preparation method Methods 0.000 claims abstract description 8
-1 C 1 -C 6 -alkanoyl Chemical group 0.000 claims description 47
229910052736 halogen Inorganic materials 0.000 claims description 34
150000002367 halogens Chemical class 0.000 claims description 34
239000001257 hydrogen Substances 0.000 claims description 21
229910052739 hydrogen Inorganic materials 0.000 claims description 21
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 20
238000006243 chemical reaction Methods 0.000 claims description 18
229960003424 phenylacetic acid Drugs 0.000 claims description 15
239000003279 phenylacetic acid Substances 0.000 claims description 15
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
125000004093 cyano group Chemical group *C#N 0.000 claims description 13
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
125000003545 alkoxy group Chemical group 0.000 claims description 10
229910021529 ammonia Inorganic materials 0.000 claims description 10
WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims description 8
239000002904 solvent Substances 0.000 claims description 8
125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 7
125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 6
125000000753 cycloalkyl group Chemical group 0.000 claims description 6
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 5
RPBDCDQMCRHNLM-UHFFFAOYSA-N C1=NNC=C2C=CC=CC2=C1 Chemical class C1=NNC=C2C=CC=CC2=C1 RPBDCDQMCRHNLM-UHFFFAOYSA-N 0.000 claims description 5
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 4
239000005695 Ammonium acetate Substances 0.000 claims description 4
235000019257 ammonium acetate Nutrition 0.000 claims description 4
229940043376 ammonium acetate Drugs 0.000 claims description 4
230000032050 esterification Effects 0.000 claims description 4
238000005886 esterification reaction Methods 0.000 claims description 4
238000009833 condensation Methods 0.000 claims description 3
230000005494 condensation Effects 0.000 claims description 3
125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 2
238000006698 hydrazinolysis reaction Methods 0.000 claims description 2
150000007978 oxazole derivatives Chemical class 0.000 claims description 2
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
150000002431 hydrogen Chemical class 0.000 claims 6
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 3
125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims 1
229940049706 benzodiazepine Drugs 0.000 abstract 1
150000001557 benzodiazepines Chemical class 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
125000004356 hydroxy functional group Chemical group O* 0.000 description 11
229960000583 acetic acid Drugs 0.000 description 9
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
125000003118 aryl group Chemical group 0.000 description 6
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
238000005160 1H NMR spectroscopy Methods 0.000 description 5
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
238000000921 elemental analysis Methods 0.000 description 5
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
150000001298 alcohols Chemical class 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
239000012043 crude product Substances 0.000 description 4
150000008282 halocarbons Chemical class 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
239000002253 acid Substances 0.000 description 3
239000000460 chlorine Substances 0.000 description 3
235000019253 formic acid Nutrition 0.000 description 3
229940093915 gynecological organic acid Drugs 0.000 description 3
150000007524 organic acids Chemical class 0.000 description 3
235000005985 organic acids Nutrition 0.000 description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
150000003254 radicals Chemical class 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
235000011114 ammonium hydroxide Nutrition 0.000 description 2
239000002585 base Substances 0.000 description 2
PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
229910052801 chlorine Inorganic materials 0.000 description 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
235000019439 ethyl acetate Nutrition 0.000 description 2
239000000284 extract Substances 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
239000000047 product Substances 0.000 description 2
238000000746 purification Methods 0.000 description 2
125000006413 ring segment Chemical group 0.000 description 2
239000007858 starting material Substances 0.000 description 2
125000001544 thienyl group Chemical group 0.000 description 2
NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
125000006728 (C1-C6) alkynyl group Chemical group 0.000 description 1
125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
125000001766 1,2,4-oxadiazol-3-yl group Chemical group [H]C1=NC(*)=NO1 0.000 description 1
125000004505 1,2,4-oxadiazol-5-yl group Chemical group O1N=CN=C1* 0.000 description 1
125000004509 1,3,4-oxadiazol-2-yl group Chemical group O1C(=NN=C1)* 0.000 description 1
YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
PDQRQJVPEFGVRK-UHFFFAOYSA-N 2,1,3-benzothiadiazole Chemical compound C1=CC=CC2=NSN=C21 PDQRQJVPEFGVRK-UHFFFAOYSA-N 0.000 description 1
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
238000005727 Friedel-Crafts reaction Methods 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
239000002841 Lewis acid Substances 0.000 description 1
CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 1
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
229910001854 alkali hydroxide Inorganic materials 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
125000003342 alkenyl group Chemical group 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
150000005840 aryl radicals Chemical class 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
CHIHQLCVLOXUJW-UHFFFAOYSA-N benzoic anhydride Chemical compound C=1C=CC=CC=1C(=O)OC(=O)C1=CC=CC=C1 CHIHQLCVLOXUJW-UHFFFAOYSA-N 0.000 description 1
125000002619 bicyclic group Chemical group 0.000 description 1
239000004305 biphenyl Substances 0.000 description 1
235000010290 biphenyl Nutrition 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
125000001589 carboacyl group Chemical group 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
HXCKCCRKGXHOBK-UHFFFAOYSA-N cycloheptane Chemical compound [CH]1CCCCCC1 HXCKCCRKGXHOBK-UHFFFAOYSA-N 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
125000002541 furyl group Chemical group 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
LFKYBJLFJOOKAE-UHFFFAOYSA-N imidazol-2-ylidenemethanone Chemical compound O=C=C1N=CC=N1 LFKYBJLFJOOKAE-UHFFFAOYSA-N 0.000 description 1
125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
239000011630 iodine Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
125000005956 isoquinolyl group Chemical group 0.000 description 1
125000001786 isothiazolyl group Chemical group 0.000 description 1
150000007517 lewis acids Chemical class 0.000 description 1
150000004702 methyl esters Chemical class 0.000 description 1
125000000896 monocarboxylic acid group Chemical group 0.000 description 1
125000002950 monocyclic group Chemical group 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
150000002916 oxazoles Chemical class 0.000 description 1
125000002971 oxazolyl group Chemical group 0.000 description 1
239000001301 oxygen Chemical group 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
125000003226 pyrazolyl group Chemical group 0.000 description 1
125000002098 pyridazinyl group Chemical group 0.000 description 1
125000004076 pyridyl group Chemical group 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
125000000168 pyrrolyl group Chemical group 0.000 description 1
125000005493 quinolyl group Chemical group 0.000 description 1
238000007127 saponification reaction Methods 0.000 description 1
150000003333 secondary alcohols Chemical class 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
125000005017 substituted alkenyl group Chemical group 0.000 description 1
125000000547 substituted alkyl group Chemical group 0.000 description 1
125000004426 substituted alkynyl group Chemical group 0.000 description 1
125000003107 substituted aryl group Chemical group 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
125000000335 thiazolyl group Chemical group 0.000 description 1
XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

BG107519A 2000-08-10 2003-02-04 МЕТОД ЗА ПОЛУЧАВАНЕ НА ИМИДАЗО (1,2-c) (2,3) БЕНЗОДИАЗЕПИНИ И МЕЖДИННИ ПРОДУКТИ ПРИ ТЯХНОТО ПОЛУЧАВАНЕ BG107519A (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10041671A DE10041671C1 (de)	2000-08-10	2000-08-10	Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung
PCT/EP2001/008661 WO2002012247A1 (de)	2000-08-10	2001-07-26	Verfahren zur herstellung von imidazo[1,2-c][2,3]benzodiazepinen und zwischenprodukte bei deren herstellung

Publications (1)

Publication Number	Publication Date
BG107519A true BG107519A (bg)	2003-06-30

Family

ID=7653689

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG107519A BG107519A (bg)	2000-08-10	2003-02-04	МЕТОД ЗА ПОЛУЧАВАНЕ НА ИМИДАЗО (1,2-c) (2,3) БЕНЗОДИАЗЕПИНИ И МЕЖДИННИ ПРОДУКТИ ПРИ ТЯХНОТО ПОЛУЧАВАНЕ

Country Status (30)

Country	Link
US (1)	US6784292B2 (tr)
EP (1)	EP1307460B1 (tr)
JP (1)	JP2004505981A (tr)
KR (1)	KR20030021263A (tr)
CN (1)	CN1205213C (tr)
AT (1)	ATE260921T1 (tr)
AU (2)	AU2001278512B2 (tr)
BG (1)	BG107519A (tr)
BR (1)	BR0112810A (tr)
CA (1)	CA2417804A1 (tr)
CZ (1)	CZ2003676A3 (tr)
DE (2)	DE10041671C1 (tr)
DK (1)	DK1307460T3 (tr)
EA (1)	EA005570B1 (tr)
EE (1)	EE200300058A (tr)
ES (1)	ES2217173T3 (tr)
HR (1)	HRP20030174A2 (tr)
HU (1)	HUP0301500A3 (tr)
IL (1)	IL154165A0 (tr)
MX (1)	MXPA02012913A (tr)
NO (1)	NO20030605D0 (tr)
NZ (1)	NZ523479A (tr)
PL (1)	PL359586A1 (tr)
PT (1)	PT1307460E (tr)
SK (1)	SK2892003A3 (tr)
TR (1)	TR200401281T4 (tr)
UA (1)	UA79737C2 (tr)
WO (1)	WO2002012247A1 (tr)
YU (1)	YU8903A (tr)
ZA (1)	ZA200301862B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8173806B2 (en) *	2006-03-17	2012-05-08	Mitsubishi Gas Chemical Company, Inc.	Method for production of quinazolin-4-one derivative
KR200453637Y1 (ko) *	2009-06-23	2011-05-19	(주)대양스톤	씽크대용 볼 고정장치
CN104498543B (zh) *	2015-01-22	2017-10-31	中国石油大学(华东)	一种脂肪酶催化合成乙偶姻脂肪酸酯的方法
CN104557533A (zh) *	2015-01-22	2015-04-29	中国石油大学(华东)	一种磷钨酸催化合成乙偶姻短链脂肪酸酯的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19604919A1 (de) *	1996-02-01	1997-08-07	Schering Ag	Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
HUP9701325A1 (hu)	1997-07-31	2000-08-28	Gyógyszerkutató Intézet Kft.	Új 2,3-benzodiazepin-származékok

2000
- 2000-08-10 DE DE10041671A patent/DE10041671C1/de not_active Expired - Lifetime
2001
- 2001-07-26 AU AU2001278512A patent/AU2001278512B2/en not_active Ceased
- 2001-07-26 CA CA002417804A patent/CA2417804A1/en not_active Abandoned
- 2001-07-26 PL PL01359586A patent/PL359586A1/xx not_active Application Discontinuation
- 2001-07-26 PT PT01956566T patent/PT1307460E/pt unknown
- 2001-07-26 IL IL15416501A patent/IL154165A0/xx unknown
- 2001-07-26 HU HU0301500A patent/HUP0301500A3/hu unknown
- 2001-07-26 KR KR10-2003-7001796A patent/KR20030021263A/ko not_active Ceased
- 2001-07-26 ES ES01956566T patent/ES2217173T3/es not_active Expired - Lifetime
- 2001-07-26 AT AT01956566T patent/ATE260921T1/de not_active IP Right Cessation
- 2001-07-26 CN CNB018139876A patent/CN1205213C/zh not_active Expired - Fee Related
- 2001-07-26 NZ NZ523479A patent/NZ523479A/en unknown
- 2001-07-26 US US10/344,156 patent/US6784292B2/en not_active Expired - Fee Related
- 2001-07-26 DE DE50101634T patent/DE50101634D1/de not_active Expired - Fee Related
- 2001-07-26 TR TR2004/01281T patent/TR200401281T4/tr unknown
- 2001-07-26 BR BR0112810-8A patent/BR0112810A/pt not_active IP Right Cessation
- 2001-07-26 EA EA200300220A patent/EA005570B1/ru not_active IP Right Cessation
- 2001-07-26 UA UA2003032066A patent/UA79737C2/uk unknown
- 2001-07-26 AU AU7851201A patent/AU7851201A/xx active Pending
- 2001-07-26 JP JP2002518222A patent/JP2004505981A/ja active Pending
- 2001-07-26 CZ CZ2003676A patent/CZ2003676A3/cs unknown
- 2001-07-26 WO PCT/EP2001/008661 patent/WO2002012247A1/de not_active Ceased
- 2001-07-26 DK DK01956566T patent/DK1307460T3/da active
- 2001-07-26 EP EP01956566A patent/EP1307460B1/de not_active Expired - Lifetime
- 2001-07-26 HR HR20030174A patent/HRP20030174A2/hr not_active Application Discontinuation
- 2001-07-26 EE EEP200300058A patent/EE200300058A/xx unknown
- 2001-07-26 MX MXPA02012913A patent/MXPA02012913A/es active IP Right Grant
- 2001-07-26 YU YU8903A patent/YU8903A/sh unknown
- 2001-07-26 SK SK289-2003A patent/SK2892003A3/sk unknown
2003
- 2003-02-04 BG BG107519A patent/BG107519A/bg unknown
- 2003-02-07 NO NO20030605A patent/NO20030605D0/no not_active Application Discontinuation
- 2003-03-06 ZA ZA200301862A patent/ZA200301862B/en unknown

Also Published As

Publication number	Publication date
EP1307460B1 (de)	2004-03-03
ATE260921T1 (de)	2004-03-15
PT1307460E (pt)	2004-07-30
SK2892003A3 (en)	2003-09-11
AU2001278512B2 (en)	2006-09-07
CA2417804A1 (en)	2003-01-30
BR0112810A (pt)	2003-07-01
YU8903A (sh)	2006-01-16
US6784292B2 (en)	2004-08-31
EA005570B1 (ru)	2005-04-28
DE10041671C1 (de)	2002-06-13
NO20030605L (no)	2003-02-07
CN1446220A (zh)	2003-10-01
EA200300220A1 (ru)	2003-08-28
MXPA02012913A (es)	2003-10-14
NZ523479A (en)	2006-10-27
EP1307460A1 (de)	2003-05-07
KR20030021263A (ko)	2003-03-12
JP2004505981A (ja)	2004-02-26
UA79737C2 (en)	2007-07-25
EE200300058A (et)	2004-12-15
TR200401281T4 (tr)	2004-07-21
HUP0301500A3 (en)	2007-07-30
IL154165A0 (en)	2003-07-31
CN1205213C (zh)	2005-06-08
ZA200301862B (en)	2004-03-08
DK1307460T3 (da)	2004-06-28
DE50101634D1 (de)	2004-04-08
CZ2003676A3 (cs)	2003-06-18
HRP20030174A2 (en)	2004-06-30
ES2217173T3 (es)	2004-11-01
HUP0301500A2 (hu)	2003-08-28
WO2002012247A1 (de)	2002-02-14
NO20030605D0 (no)	2003-02-07
PL359586A1 (en)	2004-08-23
US20040019041A1 (en)	2004-01-29
AU7851201A (en)	2002-02-18

Publication	Publication Date	Title
NZ209209A (en)	1988-02-12	Substituted phenyl-aliphatic isoxazole derivatives and pharmaceutical compositions
WO2009046624A1 (en)	2009-04-16	Preparation methods of (4s,5r)-semi-esters
Matsuo et al.	1984	Syntheses of the Novel Furo [3, 4-b][1, 5] benzodiazepinone and Pyrrolo [3, 4-b][1, 5] benzodiazepinone Systems
Gardikis et al.	2011	Xanthones in Heterocyclic Synthesis: An Efficient Route for the Synthesis of C-3 O-hydroxyaryl Substituted 1, 2-Benzisoxazoles and Their N-oxides, Potential Scaffolds for Angiotensin (II) Antagonist Hybrid Peptides
AU2001278512B2 (en)	2006-09-07	Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
CN107868087B (zh)	2020-03-24	一种制备吡咯并吲哚类衍生物的方法
Jiang et al.	2003	A convenient stereoselective synthesis of trifluoromethyl-substituted polyfunctionalized cyclopropane: synthesis of (±)-trans-trifluoronorcoronamic acid
Rowland et al.	1988	Structures of Marvel's. delta.-lactone and polymer
JPS6135194B2 (tr)	1986-08-12
CN101891716B (zh)	2012-01-04	一种S-β-羟基-γ-丁内酯的合成方法
CN116162054B (zh)	2025-06-24	一种多取代咔唑类化合物的合成方法
CN110963894B (zh)	2022-09-02	穿心莲内酯化合物及其制备方法和用途
RU2417995C1 (ru)	2011-05-10	Способ получения 3-(2-замещенных-1,3-оксазол-4-ил)пиридин-2(1н)-онов
KR900004909B1 (ko)	1990-07-09	디히드로-3-메틸-1,4-옥사티인 유도체의 제조방법
SU1038341A1 (ru)	1983-08-30	Способ получени @ -арилиндолотриметинцианинов
El-Ablack et al.	2015	Michael Reaction of 3-aAryl-2, 4-Dicarboethoxy-5-Hydroxy-5-Methylcyclohexanones
Tanimori et al.	1993	Total synthesis of (±)-chokolic acid A
Struharik et al.	1985	Claisen condensation of dimethyl 2, 3-thiophenedicarboxylate with methyl acetate and acetonitrile
CN103923142A (zh)	2014-07-16	一种罗红霉素中间体的制备方法
Kouno et al.	1984	The structures of pseudoanisatin and its novel base-catalysed rearrangement product
JPH0948773A (ja)	1997-02-18	プロスタグランジンの中間体及びその製造方法
CN110003235A (zh)	2019-07-12	异噁唑并琥珀酰亚胺类化合物及其合成方法
JP2005089430A (ja)	2005-04-07	二つのエキソメチレンを有する７員環式化合物およびその製造方法
JP2003512462A (ja)	2003-04-02	オキサゾリン誘導体の立体選択的合成方法
JPH02218675A (ja)	1990-08-31	６―フルオロクロモン―２―カルボン酸及びその製造法